ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641009 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641009; 2) Community: the network communities that were significantly associated with the response to NSC 641009; 3) Molecule: the relationships between components within communities and NSC 641009; 4) MDR: the compounds that were significantly associated with the NSC 641009.

NSC Compound Enrichment Correlation
NSC 754240 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one 0.0382675857669585 0.35622768
NSC 756134 GSK1023156A 0.0382675857669585 0.26247228
NSC 756170 GSK317315A 0.0382675857669585 0.29390027
NSC 757946 (1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-hydroxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0382675857669585 -0.3717282
NSC 83492 Null 0.0382675857669585 0.16727925
NSC 100290 Doxypyrromycin hydrochloride 0.0382675857669588 0.46342437
NSC 123978 Sarveroside 0.0382675857669588 0.23533987
NSC 131258 Null 0.0382675857669588 0.30525248
NSC 133072 Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) 0.0382675857669588 0.39547696
NSC 207895 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0382675857669588 0.3488861
Total:96  Current:76    [First] [Prev] [Next] [Last]